
    
      Patients receive intravenous DS-4152 by infusion weekly for 4 weeks, followed by 2 weeks of
      rest; courses may repeat. Patients undergo weekly follow-up. A punch biopsy will be obtained
      from patients with Kaposi's sarcoma.
    
  